Press + media

Explore the New Frontier of Pharma

With the latest Windgap news, research, and events

Get the Latest

Featured
Windgap Medical Welcomes Mike Ratigan as Business Development Advisor

WATERTOWN, Mass., June 25, 2026 — Windgap Medical, Inc., a drug-device combination product company developing dual-cartridge autoinjector platforms for complex injectable drugs, is pleased to announce that Mike Ratigan has joined the company as a Business Development Advisor.

View Press Release →

Windgap Medical Expands Capacity with Investment in Next-Generation Testing Infrastructure

Windgap Medical announced a significant expansion of its testing capabilities through investment in next-generation infrastructure. The new equipment enhances Windgap’s ability to conduct rigorous performance and reliability testing for its autoinjector platforms, supporting accelerated timelines for drug-device combination product development across its customer programs.

View Press Release →

Windgap Medical Advances to Next Phase with Leading Pharmaceutical Partner for Its OneMix Platform

Windgap Medical announced advancement to the next phase of development with a leading pharmaceutical partner using its OneMix platform, a single-use autoinjector designed for mixing and delivering combination drug products. The milestone reflects continued progress in translating Windgap’s proprietary delivery technologies into viable commercial drug-device combinations.

View Press Release →

Windgap Medical Announces Multi-Program Collaboration with Top 5 Global Pharmaceutical Company

Windgap Medical announced a strategic multi-program collaboration with a top 5 global pharmaceutical company to advance drug-device combination products using Windgap’s proprietary autoinjector platforms. The partnership encompasses multiple programs and underscores the growing demand for Windgap’s innovative delivery technologies in complex drug formulations.

View Press Release →

Beyond the Barrel: A Dual-Cartridge Improvement to Traditional Dual-Chamber Devices
Beyond the Barrel: A Dual-Cartridge Improvement to Traditional Dual-Chamber Devices

Dr. Brent Buchine explores how Windgap Medical’s parallel dual-cartridge architecture delivers significant advantages over traditional dual-chamber cartridge configurations for the mixing and delivery of combination drug products.

Injecting Sustainability: The 4th “R”—Responsibility
Injecting Sustainability: The 4th “R”—Responsibility

How Windgap is reducing environmental impact through innovation, partnerships, and a proactive approach.

Reducing Energy: Eliminating The Cold Chain
Reducing Energy: Eliminating The Cold Chain

How Windgap Medical’s lyophilized autoinjector platforms cut CO2 Emissions and Costs

Reducing Operational Waste: Streamlining Drug Development with Innovative Autoinjectors
Reducing Operational Waste: Streamlining Drug Development with Innovative Autoinjectors

Discover how automating, accelerating, and simplifying complex drug delivery can save time, resources, energy—and the planet.

Injecting Sustainability: Maximizing Complex Formulations to Minimize Carbon Footprints
Injecting Sustainability: Maximizing Complex Formulations to Minimize Carbon Footprints

Find out how lyophilization, long-acting injectables, and sequential delivery can substantially reduce waste and environmental impact.

Challenging the “3R” Rhetoric in the Autoinjector Industry
Challenging the “3R” Rhetoric in the Autoinjector Industry

Pharmaceutical companies that want to ‘move the needle’ on sustainability efforts can take a more proactive approach to reduce their footprints. Here’s why.

Designing for Success: Choosing the Right Primary Drug Container for Prefilled Delivery Devices
Designing for Success: Choosing the Right Primary Drug Container for Prefilled Delivery Devices

Brent Buchine and Jason Durkin of Windgap Medical examine how the choice of primary drug container—prefilled syringe, dual-chamber syringe, or cartridge—shapes device design, fill-finish manufacturability, drug stability, and regulatory strategy for prefilled delivery devices.

Windgap Medical Profiled on ‘Drug Development & Delivery’ Website
Windgap Medical Profiled on ‘Drug Development & Delivery’ Website

Windgap Medical offers drug delivery devices that simplify, auto-mate, and accelerate the administration of complex injectables.

In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables
In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables

Brent Buchine, Miriam Silton, Jameson Woods and Andrew Ryan explore how the combination of gas power and a side-by-side cartridge configuration increases the working viscosity range for the mixing and delivery of complex injectable formulations.

Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy
Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy

Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy

Windgap Medical Appoints Jason Durkin as Vice President, SupplyChain
Windgap Medical Appoints Jason Durkin as Vice President, SupplyChain

The autoinjector platform company known for its wet-dry drug delivery technology expands the leadership team.

Windgap Medical Appoints Anthony (“Tony”) Watson as Vice President, Regulatory Affairs and Quality
Windgap Medical Appoints Anthony (“Tony”) Watson as Vice President, Regulatory Affairs and Quality

The autoinjector platform company known for its wet-dry drug delivery technology expands the leadership team.

Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO
Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO

The autoinjector platform company known for its wet-dry drug delivery technology deepens its leadership bench.

Patient-centric Design Can Be a Faster Path to Market
Patient-centric Design Can Be a Faster Path to Market

Brent Buchine considers a faster path to market for automated and easy-to-use reconstitution devices through simplification of the delivery systems.

It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology
It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology

Co-Founder Brent Buchine discusses the need for automated, easy-to-use reconstitution devices, especially in lyophilised medications, and introduces Windgap Medical’s technology platforms, which rise to the challenge.

Windgap Medical, Inc. Closes Over $39 Million of Series B-1 Investment, More Than Twenty Percent Over Its Initial Goal
Windgap Medical, Inc. Closes Over $39 Million of Series B-1 Investment, More Than Twenty Percent Over Its Initial Goal

Windgap Medical, Inc., a leading specialty pharmaceutical and drug delivery platform company, announced today that it has successfully completed its final close with over $39 million of Series B-1 equity financing, led by Taiwania Capital.

Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector
Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector

Under the grant, researchers from the University's Center for Drug Design, College of Pharmacy, and Massachusetts-based pharmaceutical company Windgap Medical are collaborating to design an autoinjector.

Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector
Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector

Windgap Medical, Inc. announced today that it has a strategic partnership with ALK-Abelló, A/S ("ALK") to commercialize the company's epinephrine autoinjector (EAI) for the treatment of anaphylactic shock.

Windgap Medical Announces Strategic Investment from Molex Ventures
Windgap Medical Announces Strategic Investment from Molex Ventures

Windgap Medical, Inc. announced today that it has finalized a deal to enable a strategic investment from Molex Ventures, LLC, a subsidiary of Koch Industries ("Molex Ventures").

Massachusetts Life Sciences Center Board Approves New Round of Accelerator Program Loans
Massachusetts Life Sciences Center Board Approves New Round of Accelerator Program Loans

Announces next round of Life Sciences Accelerator Loan Program

Explore the Research

Featured
Beyond the Barrel: A Dual-Cartridge Improvement to Traditional Dual-Chamber Devices
Beyond the Barrel: A Dual-Cartridge Improvement to Traditional Dual-Chamber Devices

Dr. Brent Buchine explores how Windgap Medical’s parallel dual-cartridge architecture delivers significant advantages over traditional dual-chamber cartridge configurations for the mixing and delivery of combination drug products.

Designing for Success: Choosing the Right Primary Drug Container for Prefilled Delivery Devices
Designing for Success: Choosing the Right Primary Drug Container for Prefilled Delivery Devices

Brent Buchine and Jason Durkin of Windgap Medical examine how the choice of primary drug container—prefilled syringe, dual-chamber syringe, or cartridge—shapes device design, fill-finish manufacturability, drug stability, and regulatory strategy for prefilled delivery devices.

Windgap Medical Profiled on ‘Drug Development & Delivery’ Website
Windgap Medical Profiled on ‘Drug Development & Delivery’ Website

Windgap Medical offers drug delivery devices that simplify, auto-mate, and accelerate the administration of complex injectables.

In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables
In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables

Brent Buchine, Miriam Silton, Jameson Woods and Andrew Ryan explore how the combination of gas power and a side-by-side cartridge configuration increases the working viscosity range for the mixing and delivery of complex injectable formulations.

Patient-centric Design Can Be a Faster Path to Market
Patient-centric Design Can Be a Faster Path to Market

Brent Buchine considers a faster path to market for automated and easy-to-use reconstitution devices through simplification of the delivery systems.

It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology
It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology

Co-Founder Brent Buchine discusses the need for automated, easy-to-use reconstitution devices, especially in lyophilised medications, and introduces Windgap Medical’s technology platforms, which rise to the challenge.

Follow us on LinkedIn

@WindgapMedical